Last edition
News about "Denosumab price regulation"
NPPA to Cut Prices of 137 Anti-Cancer Drugs by Up to 70 Percent
NPPA has rationalised trade margins on 137 non-scheduled anti-cancer drugs, with MRPs expected to fall by up to 70 percent to improve affordability and access.
Denosumab Price Regulation | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members